skip to main content

Hypoxia-Mesenchymal Stem Cell Exosomes As A Novel Therapy Targeting Socs3/Stat3 Signaling In Androgenic Alopecia

1Department of Postgraduate Biomedical Science, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia

21. Department of Postgraduate Biomedical Science, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia

32. Department of Surgery, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia

4 Department of Pediatrics, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia

View all affiliations
Received: 3 Sep 2025; Revised: 22 Mar 2026; Accepted: 15 Apr 2026; Available online: 29 Aug 2026; Published: 31 Aug 2026.
Open Access Copyright (c) 2026 Journal of Biomedicine and Translational Research
Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Citation Format:
Abstract

Background: Androgenetic alopecia (AGA) is the most common form of hair loss, characterized by progressive follicular miniaturization associated with dysregulation of suppressor of cytokine signaling 3 (SOCS3) and signal transducer and activator of transcription 3 (STAT3). Current therapies, such as minoxidil, provide limited efficacy and are often accompanied by side effects. Exosomes derived from hypoxia-conditioned mesenchymal stem cells (EH-MSCs) offer regenerative, immunomodulatory, and anti-inflammatory effects that may represent a novel therapeutic approach.

Objective: To evaluate the therapeutic potential of EH-MSC exosomes in regulating SOCS3 and STAT3 signaling in a dihydrotestosterone-induced AGA mouse model.

Methods: An in vivo randomized post-test–only control group design was conducted using thirty-four male C57BL/6 mice divided into five groups: healthy control (K1), DHT-induced AGA + saline (K2), DHT-induced + minoxidil 5% (K3), DHT-induced + EH-MSC exosomes 100 μg/kg (K4), and DHT-induced + EH-MSC exosomes 200 μg/kg (K5). Exosomes were isolated from hypoxia-preconditioned umbilical cord MSCs using tangential flow filtration and validated with CD63/CD9 markers by flow cytometry. SOCS3 and STAT3 expression levels were analyzed by qRT-PCR. Statistical tests included Shapiro–Wilk, Levene’s, one-way ANOVA, and post hoc analysis.

Results: EH-MSC exosomes significantly modulated SOCS3 and STAT3 expression in a dose-dependent manner. The high-dose EH-MSC group (K5) restored SOCS3 expression (1.25 ± 0.18 pg/mL) to levels comparable with healthy controls (1.00 ± 0.00 pg/mL) and suppressed STAT3 expression (0.89 ± 0.15 pg/mL) toward normal values. Minoxidil only partially improved SOCS3 (0.49 ± 0.16 pg/mL) and STAT3 (2.32 ± 0.19 pg/mL) expression compared to untreated AGA controls.

Conclusion: Exosomes derived from hypoxia-preconditioned MSCs demonstrated superior immunomodulatory effects compared to minoxidil by enhancing SOCS3 and suppressing STAT3 expression, thereby restoring follicular homeostasis in AGA. These findings suggest EH-MSC exosomes as a promising exosome-based therapeutic strategy for androgenetic alopecia, with potential implications for clinical nursing practice in regenerative dermatology.

Keywords: Androgenic Alopecia; Mesenchymal Stem Cells; Exosomes; Cell Hypoxia; Signal Transduction

Article Metrics:

Article Info
Section: Original Research Articles
Language : EN
  1. Darmaningrat A, Ari S, Lousiana S, Nurhidayati. Alopesia Androgenetik: Mengenali Manifestasi Klinis Hingga Tatalaksana. JUKEJ: Jurnal Kesehatan Jompa 2022; 1: 109–117
  2. Gokce N, Basgoz N, Kenanoglu S, Akalin H, Ozkul Y, Ergoren MC et al. An overview of the genetic aspects of hair loss and its connection with nutrition. J Prev Med Hyg. 2022; 63: E228–E238
  3. Cao W, Meng X, Cao F, Wang J, Yang M. Exosomes derived from platelet-rich plasma promote diabetic wound healing via the JAK2/STAT3 pathway. iScience 2023; 26. doi: 10.1016/j.isci.2023.108236
  4. English RS. A hypothetical pathogenesis model for androgenic alopecia: Clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. Med Hypotheses 2018; 111: 73–81
  5. Su LH, Chen THH. Association of androgenetic alopecia with metabolic syndrome in men: A community-based survey. British Journal of Dermatology 2010; 163: 371–377
  6. Wang G, Wang Z, Zhang J, Shen Y, Hou X, Su L et al. Treatment of androgenetic alopecia by exosomes secreted from hair papilla cells and the intervention effect of LTF. J Cosmet Dermatol 2023; 22: 2996–3007
  7. Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol 2011; 65. doi: 10.1016/j.jaad.2010.09.724
  8. Alfonso M, Richter-Appelt H, Tosti A, Viera MS, García M. The psychosocial impact of hair loss among men: A multinational European study. Curr Med Res Opin. 2005; 21: 1829–1836
  9. Williamson D, Gonzalez M, Finlay A. The effect of hair loss on quality of life. European Academy of Dermatology and Venereology 2001; 15: 137-139*
  10. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007; 7: 454–465
  11. Hillmer EJ, Zhang H, Li HS, Watowich SS. STAT3 signaling in immunity. Cytokine Growth Factor Rev. 2016; 31: 1–15
  12. Hassan AS, Al-Dhoun MQ, Shaker OG, Alorbani AM. Expression of Signal Transducer and Activator of Transcription-3 in Androgenetic Alopecia: A Case-Control Study. Skin Pharmacol Physiol 2022; 35: 278–281
  13. Gao Z, Jin Y-Q, Wu W. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction. Oncotarget 2017; 8: 33432–33443
  14. Morelli M, Madonna S, Albanesi C. SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation. Front Immunol. 2024; 15. doi: 10.3389/fimmu.2024.1393799
  15. Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil Use in Dermatology, Side Effects and Recent Patents. 2012
  16. Yang Y, Lee EH, Yang Z. Hypoxia-Conditioned Mesenchymal Stem Cells in Tissue Regeneration Application. Tissue Eng Part B Rev. 2022; 28: 966–977
  17. Maumus M, Rozier P, Boulestreau J, Jorgensen C, Noël D. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation. Front Bioeng Biotechnol. 2020; 8. doi: 10.3389/fbioe.2020.00997
  18. Schwarz G, Ren X, Xie W, Guo H, Jiang Y, Zhang J. Engineered exosomes: a promising drug delivery platform with therapeutic potential. Front Mol Biosci. 2025; 12. doi: 10.3389/fmolb.2025.1583992
  19. Ersan M, Ozer E, Akin O, Tasli PN, Sahin F. Effectiveness of Exosome Treatment in Androgenetic Alopecia: Outcomes of a Prospective Study. Aesthetic Plast Surg 2024; 48: 4262–4271
  20. Liang Y, Tang X, Zhang X, Cao C, Yu M, Wan M. Adipose Mesenchymal Stromal Cell-Derived Exosomes Carrying MiR-122-5p Antagonize the Inhibitory Effect of Dihydrotestosterone on Hair Follicles by Targeting the TGF-β1/SMAD3 Signaling Pathway. Int J Mol Sci 2023; 24. doi: 10.3390/ijms24065703
  21. Dhar K, Rakesh K, Pankajakshan D, Agrawal DK. SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 2013; 304: H776
  22. Paul S, Licona-Vázquez I, Serrano-Cano FI, Frías-Reid N, Pacheco-Dorantes C, Pathak S et al. Current insight into the functions of microRNAs in common human hair loss disorders: a mini review. Hum Cell. 2021; 34: 1040–1050
  23. Ren J, Zhu B, Gu G, Zhang W, Li J, Wang H et al. Schwann cell-derived exosomes containing MFG-E8 modify macrophage/microglial polarization for attenuating inflammation via the SOCS3/STAT3 pathway after spinal cord injury. Cell Death Dis 2023; 14. doi: 10.1038/s41419-023-05607-4
  24. Zhou G, Tian H, Jin Y, Tao X, Liu B, Zhang R et al. Catalytic oxidation of Li2S on the surface of metal sulfides for Li-S batteries. Proc Natl Acad Sci U S A 2017; 114: 840–845
  25. Shimizu Y, Ntege EH, Sunami H, Inoue Y. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature. Regen Ther. 2022; 21: 527–539

Last update:

No citation recorded.

Last update:

No citation recorded.